101 related articles for article (PubMed ID: 15498350)
1. [Expression of pRb and E2F-1 and telomerase activity in ameloblastoma].
Zhong M; Wang J; Zhang B; Hou L; Yue YL; Li ZJ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Sep; 39(5):406-9. PubMed ID: 15498350
[TBL] [Abstract][Full Text] [Related]
2. [Expression of telomerase activity and cyclin A in ameloblastoma].
Zhong M; Yue YL; Wang J; Wang ZY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Jul; 38(4):257-60. PubMed ID: 12930651
[TBL] [Abstract][Full Text] [Related]
3. [Expression of p21WAF1, p27KIP1 and cyclin E in ameloblastoma].
Zhong M; Liu J; Gong YB; Liu JD; Wang J; Zhang B
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Jul; 40(4):306-9. PubMed ID: 16191374
[TBL] [Abstract][Full Text] [Related]
4. [Expression of human telomerase reverse transcriptase and bcl-2 in ameloblastoma].
Wang J; Zhong M; Wang Z
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Dec; 21(6):441-3. PubMed ID: 14732976
[TBL] [Abstract][Full Text] [Related]
5. [Expression of telomerase and p53 in ameloblastoma].
Zhong M; Zhang LH; Wang J; Zhang B; Hou L
Shanghai Kou Qiang Yi Xue; 2003 Apr; 12(2):127-31. PubMed ID: 14661519
[TBL] [Abstract][Full Text] [Related]
6. [Effect of telomerase on ginsenoside Rh2-induced differentiation of hepatocarcinoma cell line SMMC-7721].
Zeng XL; Tu ZG
Ai Zheng; 2004 Dec; 23(12):1655-9. PubMed ID: 15601555
[TBL] [Abstract][Full Text] [Related]
7. [DNA methylation of human telomerase reverse transcriptase promoter region in human ameloblastoma].
Zhong M; Yan Y; Wang J; Liu J; Li L; Gong YB
Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 May; 42(5):304-7. PubMed ID: 17686286
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of E2F-1 and Rb expression with papillomatosis and ductal carcinoma in situ of the breast].
Niu Y; Li Y; Niu RF; Lü AJ; Fu XL
Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):290-3. PubMed ID: 15312366
[TBL] [Abstract][Full Text] [Related]
9. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.
Alonso MM; Fueyo J; Shay JW; Aldape KD; Jiang H; Lee OH; Johnson DG; Xu J; Kondo Y; Kanzawa T; Kyo S; Bekele BN; Zhou X; Nigro J; McDonald JM; Yung WK; Gomez-Manzano C
J Natl Cancer Inst; 2005 Nov; 97(21):1589-600. PubMed ID: 16264179
[TBL] [Abstract][Full Text] [Related]
10. [The study of the invasive biologic behavior of ameloblastoma].
Zhong M; Li ZJ; Wang J; Yue YL; Bao G
Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Jan; 39(1):45-8. PubMed ID: 14989873
[TBL] [Abstract][Full Text] [Related]
11. [Expression of telomerase activity and c-myc and stimulatory protein 1 in human ameloblastoma].
Zhong M; Li ZJ; Wang J; Zhang B; Hou L; Gong YB
Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Dec; 22(6):499-502. PubMed ID: 15656532
[TBL] [Abstract][Full Text] [Related]
12. Telomere shortening and telomerase reverse transcriptase expression in preinvasive bronchial lesions.
Lantuejoul S; Soria JC; Morat L; Lorimier P; Moro-Sibilot D; Sabatier L; Brambilla C; Brambilla E
Clin Cancer Res; 2005 Mar; 11(5):2074-82. PubMed ID: 15756034
[TBL] [Abstract][Full Text] [Related]
13. E2F-1 overexpression in U2OS cells increases cyclin B1 levels and cdc2 kinase activity and sensitizes cells to antimitotic agents.
Russo AJ; Magro PG; Hu Z; Li WW; Peters R; Mandola J; Banerjee D; Bertino JR
Cancer Res; 2006 Jul; 66(14):7253-60. PubMed ID: 16849574
[TBL] [Abstract][Full Text] [Related]
14. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
[TBL] [Abstract][Full Text] [Related]
15. Increased E2F-1 expression via tumour cell proliferation and decreased apoptosis are correlated with adverse prognosis in patients with squamous cell carcinoma of the oesophagus.
Yamazaki K; Hasegawa M; Ohoka I; Hanami K; Asoh A; Nagao T; Sugano I; Ishida Y
J Clin Pathol; 2005 Sep; 58(9):904-10. PubMed ID: 16126868
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of retinoblastoma protein and E2 promoter-binding factor-1 in ameloblastomas.
Kumamoto H; Ooya K
J Oral Pathol Med; 2006 Mar; 35(3):183-9. PubMed ID: 16454815
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells.
Tomari K; Kumagai T; Shimizu T; Takeda K
Int J Mol Med; 2005 Feb; 15(2):253-8. PubMed ID: 15647840
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative effects of gefitinib are associated with suppression of E2F-1 expression and telomerase activity.
Suenaga M; Yamaguchi A; Soda H; Orihara K; Tokito Y; Sakaki Y; Umehara M; Terashi K; Kawamata N; Oka M; Kohno S; Tei C
Anticancer Res; 2006; 26(5A):3387-91. PubMed ID: 17094457
[TBL] [Abstract][Full Text] [Related]
19. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
Takihana Y; Tsuchida T; Fukasawa M; Araki I; Tanabe N; Takeda M
Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
[TBL] [Abstract][Full Text] [Related]
20. The telomerase activity and expression of hTERT gene can serve as indicators in the anti-cancer treatment of human ovarian cancer.
Sun PM; Wei LH; Luo MY; Liu G; Wang JL; Mustea A; Könsgen D; Lichtenegger W; Sehouli J
Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):249-57. PubMed ID: 16519988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
